Molecular study of Pompe disease in Egyptian infants
Abstract Background Pompe disease (PD) is a serious genetic disorder caused by deficiency of acid α-glucosidase (GAA) and subsequent glycogen accumulation inside lysosomes. This study included a cohort of 5 Egyptian infants (1–8 months old) with far lower than average normal GAA activity and clinica...
Guardado en:
Autores principales: | Mona Essawi, Nagham ElBagoury, Engy Ashaat, Wessam Sharaf-Eldin, Ekram Fateen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SpringerOpen
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/80b1f9edba774b38a0beb7b458a44e09 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
por: Antonietta Tarallo, et al.
Publicado: (2021) -
A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Alícia Dorneles Dornelles, et al.
Publicado: (2021) -
Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
por: Javier de las Heras, et al.
Publicado: (2021) -
Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report
por: Zhang B, et al.
Publicado: (2016) -
Fabrication and Biological Assessment of Antidiabetic α-Mangostin Loaded Nanosponges: In Vitro, In Vivo, and In Silico Studies
por: Faisal Usman, et al.
Publicado: (2021)